Mouse IgG1 Isotype Control (Clone HKSP) - Purified in vivo GOLD™ Functional Grade
| Code | Size | Price |
|---|
| LEI-I-536-1.0mg | 1.0 mg | £175.00 |
Quantity:
| LEI-I-536-5.0mg | 5.0 mg | £380.00 |
Quantity:
| LEI-I-536-25mg | 25 mg | £1,014.00 |
Quantity:
| LEI-I-536-50mg | 50 mg | £1,556.00 |
Quantity:
| LEI-I-536-100mg | 100 mg | £2,159.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Isotype Control
Antibody Clone: HKSP
Regulatory Status: RUO
Applications:
- Flow Cytometry
- In Vivo Assay
Shipping:
2-8°C
Storage:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Further Information
Concentration:
? 5.0 mg/ml
Conjugate/Tag/Label:
in vivo GOLD™, Purified in vivo Functional Grade
Format:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:
?95% monomer by analytical SEC, >95% by SDS Page
References
1.) Crack, Peter J. et al. (2016) eNeuro 10.1523/ENEURO.0128-15.2016 Article Link
2.) Shin, Haina et al. (2018) J Virol. 92(7): e00038-18. PubMed
3.) Karki et al. (2021) Cell. 184:149?168 Journal Link
4.) Ortiz et al. (2019) Cancer Cell. 35:33?45 Journal Link
5.) Smyth et al. (2020) Cancer Immunol Res 8:1-12 Journal Link
6.) Swaminathan, S. et al. (2020) Nat Commun 11: 2860 Journal Link
7.) Karki, R. et al. (2020) Cell 184(1):149?168.e17 Journal Link
Related Products
| Product Name | Product Code | Supplier | Anti-Human Casp-4 (Intermediate Domain) | LEI-C1221 | Leinco Technologies | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human Casp-4 (NT) | LEI-C1222 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||